Astragalus polysaccharide (APS) treatment significantly increased the ratio of CD4+ T cell and the CD4/CD8 T cell ratio in mice with lung cancer, along with elevating blood levels of IFN-γ and IL-2. This evidence concerns the gene CD4 and lung cancer.